Skip to main content
Tanvex logo

Tanvex — Investor Relations & Filings

Ticker · 6541 ISIN · KYG8676P1037 TW Manufacturing
Open in API
Filings indexed 32 across all filing types
Latest filing 2026-06-05 Governance Information
Country TW Taiwan
Listing TW 6541

About Tanvex

www.tanvex.com

Tanvex BioPharma, Inc. specializes in the research, development, manufacturing, and commercialization of biosimilars and innovative biologics. The company operates a vertically integrated model encompassing cell line development, process optimization, and clinical to commercial-scale production. Its portfolio focuses on biosimilars for oncology and supportive care, alongside emerging Antibody-Drug Conjugate (ADC) programs. Tanvex provides comprehensive Contract Development and Manufacturing Organization (CDMO) services, offering a unified platform that supports early-stage development through to commercial manufacturing. By maintaining GMP-compliant facilities and achieving regulatory approval for its biosimilar products, the company delivers end-to-end solutions aimed at increasing the accessibility of safe and effective treatments in international markets.

Recent filings

Filing Released Lang Actions
功能性委員會成員
Governance Information Classification · 82% confidence The document is a corporate governance disclosure from the public information observation station showing the composition of the audit committee, independent directors, and board structure for company code 6541. It details internal governance practices rather than announcing a report or management change. This aligns with the Governance Information (CGR) category.
2026-06-05 Chinese
公告本公司審計委員會異動
Board/Management Information Classification · 85% confidence The document is a regulatory announcement on the Taiwan market information system detailing a change in the company’s Audit Committee membership (a board committee appointment). It is not financial data or an earnings report but an organizational change notice. This falls under Board/Management Information (MANG).
2026-06-04 Chinese
公告本公司115年股東常會決議解除董事競業禁止之限制
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a formal disclosure of the 115/06/04 shareholders’ meeting resolution, detailing the vote outcome on lifting competitive restrictions for directors. It is the official result announcement from a general meeting, matching the Declaration of Voting Results & Voting Rights Announcements category.
2026-06-04 Chinese
公告本公司115年股東常會補選獨立董事當選名單
Board/Management Information Classification · 88% confidence The document is an announcement by the company of the election of a new independent director at its shareholders’ meeting, detailing the change in board composition (new independent director’s name, effective date, term, etc.). This is a classic Board/Management Information filing, not a full annual or interim report, nor simply voting tallies or AGM materials.
2026-06-04 Chinese
公告本公司115年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an official announcement of the important resolutions passed at the company’s 2026 (ROC 115) Annual General Meeting, listing the shareholders’ meeting date and each resolution approved (earnings distribution, charter amendments, business report and financials, director elections, and other matters). This corresponds exactly to Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings.
2026-06-04 Chinese
公司基本資料
Regulatory Filings Classification · 11% confidence The document is a standard public information filing from the Taiwan ‘公開資訊觀測站’ containing the company’s basic identification, contact, share capital, auditors, listing dates, principal business, etc. It does not present any financial statements or detailed quarterly/full-year results, nor is it an announcement of a report being published. It is a generic regulatory disclosure of corporate information, best classified under the fallback category for miscellaneous regulatory filings (RNS).
2026-06-01 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.